兽药市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

兽药市场按产品类型(药物、疫苗和药用饲料添加剂)、动物类型(伴侣动物和家畜)和地理(北美、欧洲、亚太地区、中东和非洲以及南美国)。该报告提供了上述细分市场的价值(以百万美元计)。

市场快照

Veterinary Medicine Market Overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.56 %
Veterinary Medicine Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

2020年兽药市场价值426.3376亿美元,预计到2026年将达到657.9709亿美元,预测期内复合年增长率为7.56%。

COVID-19 的爆发影响了所有行业,包括兽医行业。Idexx 实验室和其他主要参与者已经对数千只狗和猫进行了病毒检测;测试结果通常为阴性。但是,仍建议宠物主人与宠物保持距离,以保持卫生并降低污染风险。在畜牧业也观察到了 COVID-19 的影响。供应链中断,导致肉、奶、蛋等动物产品难以进入市场。对反刍动物的季节性过境也实施了限制。然而,为了迎合中断的供需链,粮食及农业组织在 2020 年 4 月,

兽药市场增长的主要因素是动物慢性病负担的增加、动物收养的增加以及宠物和家禽农场主对药物偏好的增加,再加上人口的持续增长,导致对肉类和动物制品的需求增加。根据疾病控制和预防中心的说法,人畜共患疾病在美国和世界各地都非常普遍。Ss,据估计,人类每10种已知传染病中就有6种以上可以通过动物传播,每4种新发或新发传染病中就有3种以上来自动物。

目前,全球牲畜数量也在激增。根据美国农业部的数据,2020 年 7 月,截至 2020 年 7 月,美国约有 1.03 亿头牛和 3210 万头肉牛,预计未来几年将大幅增长。此外,研究和开发投资的增加、宠物收养率的提高以及肉类消费量的增长以及对动物的强制性疫苗接种预计将在不久的将来增加对兽药和动物疫苗的需求。根据美国宠物产品协会(APPA)的数据,2018 年美国人在宠物行业的支出为 725.6 亿美元,2019 年为 753.8 亿美元,比十年前增长了 65%。

此外,肉类消费量的增加是市场增长的主要推动因素之一。据丹麦 The World Counts 报道,2018 年,据观察,从 1988 年到 2018 年,全球肉类产量增长了两倍。它还表示,到 2050 年,肉类消费量估计在 460 到 5.7 亿吨之间。肉类消费量的增加将增加对兽药的需求,因为将采用更多的药物来使这种牲畜免受疾病侵害。

报告范围

兽医专业人员使用兽药来治疗疾病、伤害和帮助动物生长。这些主要用于治疗疾病和防止传染病在动物之间传播。这些药物通过限制传染病从动物到人类的传播,间接造福于人类医疗保健。市场按产品类型(药物、疫苗和药用饲料添加剂)、动物类型(伴侣动物和家畜)和地理(北美、欧洲、亚太地区、中东和非洲以及南美)细分. 市场报告还涵盖了全球主要地区 17 个不同国家/地区的估计市场规模和趋势。该报告提供了上述细分市场的价值(以百万美元计)。

该报告还提供了整个产品类型(药物、疫苗和药用饲料添加剂)的价值(百万美元),不包括药物、疫苗和药用饲料添加剂的子部分,以及按动物类型(伴侣动物和家畜动物)作为一个整体,不包括伴侣动物和家畜动物的子部分,将为范围内提供的每个国家提供。

By Product Type
Drugs
Anti-infectives
Anti-inflammatory
Parasiticides
Other Drugs
Vaccines
Inactive Vaccines
Attenuated Vaccines
Recombinant Vaccines
Other Vaccines
Medicated Feed Additives
Aminoacids
Antibiotics
Other Medicated Feed Additives
By Animal Type
Companion Animals
Dogs
Cats
Other Companion Animals
Livestock Animals
Cattle
Poultry
Swine
Sheep
Other Livestock Animals
Geography
North America
United States (By Product Type and By Animal Type)
Canada (By Product Type and By Animal Type)
Mexico (By Product Type and By Animal Type)
Europe
Germany (By Product Type and By Animal Type)
United Kingdom (By Product Type and By Animal Type)
France (By Product Type and By Animal Type)
Italy (By Product Type and By Animal Type)
Spain (By Product Type and By Animal Type)
Rest of Europe (By Product Type and By Animal Type)
Asia-Pacific
China (By Product Type and By Animal Type)
Japan (By Product Type and By Animal Type)
India (By Product Type and By Animal Type)
Australia (By Product Type and By Animal Type)
South Korea (By Product Type and By Animal Type)
Rest of Asia-Pacific (By Product Type and By Animal Type)
Middle-East and Africa
GCC (By Product Type and By Animal Type)
South Africa (By Product Type and By Animal Type)
Rest of Middle-East and Africa (By Product Type and By Animal Type)
South America
Brazil (By Product Type and By Animal Type)
Argentina (By Product Type and By Animal Type)
Rest of South America (By Product Type and By Animal Type)

Report scope can be customized per your requirements. Click here.

主要市场趋势

疫苗板块有望占据重要市场份额

按产品划分,疫苗部分预计将占据重要市场份额。这一细分市场的增长是由对动物源性食品需求的增长、伴侣动物数量的增加、人畜共患病发病率的上升以及政府机构和动物协会为维持动物健康而采取的各种举措所推动的。根据 USDA(美国农业部)NASS(国家农业统计局)的数据,2018 年鸡蛋、肉鸡和火鸡的总产量以及鸡肉的销售额为 463 亿美元,增长约 8% 2017 年为 427 亿美元。

此外,兽用疫苗市场主要参与者的重大发展,如并购、产品开发和推出以扩大其疫苗产品组合,预计将提升市场的增长潜力。例如,2019 年 10 月,Ceva 与 ProBioGen AG 达成协议,使用 ProBioGen 的专有 AGE1.CR 技术生产矢量化家禽疫苗。该协议帮助两家公司扩大了长期合作伙伴关系和开发创新疫苗的长期记录。

Veterinary Medicine Market Key Trends

北美主导市场,预计预测期内趋势相同

迄今为止,北美一直主导着兽药市场,预计即使在预测期内也会如此。导致这种主导地位的关键因素是人畜共患病患病率的增加、有利的报销计划以及伴侣动物支出的增加。根据美国兽医协会 (AVMA) 的报告,2019 年美国在宠物方面的支出超过 957 亿美元,其中猫狗占了很大份额。此外,增加美国宠物健康保险的采用率也有望推动市场增长。该地区提供良好报销率的主要兽医医院的集中度增加,为市场增长增添了动力。

此外,还有大量主要市场参与者专注于该地区的市场发展战略。例如,2019 年,美国公司 Zoetis 与 Caritas 签署了合作协议,以提高该国罗非鱼鱼价值链的生产力和可持续性。此外,预计该伙伴关系将为罗非鱼养殖者提供鱼类健康管理和最佳水产养殖实践方面的培训。预计所有这些发展将进一步推动市场增长。

预计亚太地区的兽药市场也将在预测期内提供巨大的增长机会。伴侣动物的更多采用加上对动物的认识不断提高,促进了该地区的市场增长。此外,动物健康和兽医服务支出的增加以及牛群数量的增加是推动兽药市场的一些主要因素。

Veterinary Medicine Market Growth Rate

竞争格局

兽药市场竞争适度,由几家收入差异不大的主要参与者组成。在领先的动物保健公司中,硕腾在收入方面名列前茅。2019 年,勃林格殷格翰动物保健和梅里亚等各种组织的日益整合预计将在未来的主要参与者之间产生竞争性竞争。该市场的一些主要参与者包括 Zoetis、Bayer AG、Ceva、Merck 和 Elanco。

竞争格局

兽药市场竞争适度,由几家收入差异不大的主要参与者组成。在领先的动物保健公司中,硕腾在收入方面名列前茅。2019 年,勃林格殷格翰动物保健和梅里亚等各种组织的日益整合预计将在未来的主要参与者之间产生竞争性竞争。该市场的一些主要参与者包括 Zoetis、Bayer AG、Ceva、Merck 和 Elanco。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Chronic Disease Conditions in Animals, Coupled with the Increasing Adoption of Animals

      2. 4.2.2 Increase in Drug Preferences by Pet and Poultry Farm Owners

      3. 4.2.3 Increased Demand for Meat and Animal-based Products in Agriculture and Human Healthcare

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs Associated with Animal Healthcare

      2. 4.3.2 Lack of Awareness about Animal Health in the Emerging Nations

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Drugs

        1. 5.1.1.1 Anti-infectives

        2. 5.1.1.2 Anti-inflammatory

        3. 5.1.1.3 Parasiticides

        4. 5.1.1.4 Other Drugs

      2. 5.1.2 Vaccines

        1. 5.1.2.1 Inactive Vaccines

        2. 5.1.2.2 Attenuated Vaccines

        3. 5.1.2.3 Recombinant Vaccines

        4. 5.1.2.4 Other Vaccines

      3. 5.1.3 Medicated Feed Additives

        1. 5.1.3.1 Aminoacids

        2. 5.1.3.2 Antibiotics

        3. 5.1.3.3 Other Medicated Feed Additives

    2. 5.2 By Animal Type

      1. 5.2.1 Companion Animals

        1. 5.2.1.1 Dogs

        2. 5.2.1.2 Cats

        3. 5.2.1.3 Other Companion Animals

      2. 5.2.2 Livestock Animals

        1. 5.2.2.1 Cattle

        2. 5.2.2.2 Poultry

        3. 5.2.2.3 Swine

        4. 5.2.2.4 Sheep

        5. 5.2.2.5 Other Livestock Animals

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States (By Product Type and By Animal Type)

        2. 5.3.1.2 Canada (By Product Type and By Animal Type)

        3. 5.3.1.3 Mexico (By Product Type and By Animal Type)

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany (By Product Type and By Animal Type)

        2. 5.3.2.2 United Kingdom (By Product Type and By Animal Type)

        3. 5.3.2.3 France (By Product Type and By Animal Type)

        4. 5.3.2.4 Italy (By Product Type and By Animal Type)

        5. 5.3.2.5 Spain (By Product Type and By Animal Type)

        6. 5.3.2.6 Rest of Europe (By Product Type and By Animal Type)

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China (By Product Type and By Animal Type)

        2. 5.3.3.2 Japan (By Product Type and By Animal Type)

        3. 5.3.3.3 India (By Product Type and By Animal Type)

        4. 5.3.3.4 Australia (By Product Type and By Animal Type)

        5. 5.3.3.5 South Korea (By Product Type and By Animal Type)

        6. 5.3.3.6 Rest of Asia-Pacific (By Product Type and By Animal Type)

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC (By Product Type and By Animal Type)

        2. 5.3.4.2 South Africa (By Product Type and By Animal Type)

        3. 5.3.4.3 Rest of Middle-East and Africa (By Product Type and By Animal Type)

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil (By Product Type and By Animal Type)

        2. 5.3.5.2 Argentina (By Product Type and By Animal Type)

        3. 5.3.5.3 Rest of South America (By Product Type and By Animal Type)

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Aptimmune Biologics

      2. 6.1.2 Boehringer Ingelheim

      3. 6.1.3 Cadila Pharmaceuticals Ltd

      4. 6.1.4 Ceva Animal Health LLC

      5. 6.1.5 China Animal Husbandry Co. Ltd

      6. 6.1.6 Dechra Pharmaceuticals PLC

      7. 6.1.7 Elanco

      8. 6.1.8 Merck & Co. Inc.

      9. 6.1.9 Neogen Corporation

      10. 6.1.10 Nutreco NV

      11. 6.1.11 Phibro Animal Health Corporation

      12. 6.1.12 Sanofi SA

      13. 6.1.13 Vetoquinol SA

      14. 6.1.14 Virbac

      15. 6.1.15 Zoetis

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Veterinary Medicine Market market is studied from 2018 - 2026.

The Global Veterinary Medicine Market is growing at a CAGR of 7.56% over the next 5 years.

The Global Veterinary Medicine Market is valued at 42633 Million USD in 2018.

The Global Veterinary Medicine Market is valued at 65797 Million USD in 2026.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Zoetis , Merck & Co., Inc , Elanco , Bayer AG , Ceva are the major companies operating in Global Veterinary Medicine Market .

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!